Highland Capital Management Fund Advisors, L.P. Nektar Therapeutics Transaction History

Highland Capital Management Fund Advisors, L.P.

$651 Million
Q1 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $433,200 - $736,400	-40,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $65,350 - $94,200	-5,000 Reduced 11.11%	40,000 $718,000
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $578,200 - $714,000	35,000 Added 350.0%	45,000 $772,000
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $90,689 - $126,083	-5,379 Reduced 34.98%	10,000 $232,000
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $30,387 - $58,716	-2,100 Reduced 12.01%	15,379 $275,000

Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $277,391 - $404,114	17,479 New	17,479 $377,000

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$21.5 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$14.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$8.86 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.15 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$6.88 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account